HK inno.N
Since its establishment in 1984, inno.N has tapped into the belief that its business was also helping chart the nation’s future. This belief has served and continues to serve the company well, as it has grown into one of the leading pharmaceutical firms in the nation.
Exhibition Item
1. Rovazet2. Exone-R
3. Exone-A
4. Machkhan
Satellite Symposium
Lunchtime Activities
Synergistic Management of Hypertension and Dyslipidemia ; Mainly Focus on Fixed Dose Combination
Organized by CVRF and Supported by Educational Grant from HK inno.N
Saturday, April 27
12:45 PM ~ 1:45 PM * KST (UTC/GMT +9:00)
Room 115, Level 1
Moderator(s): Ki Hoon Han, Moo Hyun Kim
Panelist(s): Jung-Kyu Han, Woohyeun Kim
| 12:45 PM | FDC Management of Hypertension and Dyslipidemia Lecturer: Jin Joo Park |
| 1:05 PM | New Concept of Dyslipidemia Medication: The Lower, The Smaller Lecturer: Ji Hyun Kim |
| 1:25 PM | Discussion |